ABOUT SEATS X MLCC

SEATS × MLCC 2026 marks a significant milestone as the 5th Annual Congress of the South East Asian Thoracic Society (SEATS 2026) and the 6th Multi-Disciplinary Lung Cancer Conference (MLCC 2026) come together for the first time in Singapore under one roof. Through aligned scientific programmes and a shared commitment to multidisciplinary care, the joint congress creates a unique platform for learning, collaboration, and innovation across the thoracic healthcare continuum.

SEATS 2026 (11–14 November) explores the future of integrated multidisciplinary care under the theme, “Where Boundaries End, Innovation Begins – Breaking Silos Through Integration, Robotics and AI,” highlighting how robotics, artificial intelligence, and cross-specialty collaboration are reshaping clinical practice, education, and patient outcomes.

MLCC 2026 (15 November) continues the conversation with its theme, “Moving into the Era of Rational Combinations,” featuring cutting-edge advances in advanced lung cancer treatment, including targeted therapies, novel biologics, immunotherapy, and rational combination strategies.

Together, SEATS × MLCC 2026 offers an unparalleled opportunity to exchange knowledge, inspire innovation, strengthen regional and international collaborations, and advance the future of thoracic surgery, multidisciplinary lung cancer care, and patient outcomes.

Time	09:00 – 16:00 (GMT+8)
Venue	Grand Hyatt Singapore, Residence 6, Level 3
Format	Rotating hands-on stations with focused short didactic sessions and practical demonstrations
Introduction	This hands-on workshop is designed to strengthen both the technical execution and clinical reasoning required for advanced bronchoscopy and interventional pulmonology. Each station combines short expert demonstrations with deliberate practice, troubleshooting, and discussion of indications, safety checks, and complication management
Objectives	– Develop a structured approach to procedure planning, including indication, airway anatomy, lesion or nodal target, device selection, and rescue strategy. – Improve hands-on familiarity with convex-probe EBUS bronchoscopes, R-EBUS probes, guide sheaths, biopsy tools, cryoprobes, ablative devices, rigid bronchoscopes, and airway stents. – Practice stepwise technical execution with attention to ergonomics, team communication, equipment readiness, and procedural flow. – Recognise pitfalls early and apply practical strategies for bleeding, airway obstruction, pneumothorax risk, device malposition, and loss of target access.
Target Participants	Respiratory physicians, interventional pulmonologists, thoracic surgeons, respiratory and thoracic fellows and trainees, intensivists with an interest in advanced bronchoscopy, bronchoscopy nurses, and allied healthcare professionals involved in bronchoscopy services.
Participants Number	30 pax
Lead Faculty	Eric D. Tenda Melvin Tay C.K. SS Kho
Faculty	Regional and international multidisciplinary experts in respiratory medicine and interventional pulmonology

Time	07:30 – 17:00 (GMT+8)
Venue	Grand Hyatt Singapore, Residence 5, Level 3
Format	Interactive, case-based multidisciplinary workshop focused on precision lung cancer care, integrating molecular tumour board discussions, real-world case simulations, and live audience polling.
Introduction	This workshop focuses on the practical application of molecular profiling in lung cancer, including NGS, liquid biopsy, and minimal residual disease (MRD). Emphasis is placed on translating biomarker data into real-world clinical decision-making across early-stage and advanced disease settings.
Objectives	– Apply NGS and molecular profiling in lung cancer management – Interpret ctDNA and MRD results in clinical practice – Integrate biomarker data into treatment decisions – Manage early and advanced NSCLC using precision oncology approaches – Conduct multidisciplinary tumour board (MTB)–style decision-making in clinical scenarios – Discuss real-world challenges in implementing molecular diagnostics in routine practice – Evaluate emerging roles of perioperative and adjuvant biomarker-guided therapies
Target Participants	Medical oncologists, thoracic surgeons, pulmonologists, pathologists, radiation oncologists, trainees, and allied health professionals.
Lead Faculty	Aaron Tan
Faculty	Regional and international multidisciplinary experts in thoracic oncology and molecular diagnostics.

American Samoa	Gibraltar	Panama
Andorra	Greece	Poland
Antigua and Barbuda	Greenland	Portugal
Aruba	Guam	Puerto Rico
Australia	Guyana	Qatar
Austria	Hong Kong SAR, China	Romania
Bahamas, The	Hungary	Russian Federation
Bahrain	Iceland	San Marino
Barbados	Ireland	Saudi Arabia
Belgium	Isle of Man	Seychelles
Bermuda	Israel	Singapore
British Virgin Islands	Italy	Sint Maarten (Dutch part)
Brunei Darussalam	Japan	Slovak Republic
Bulgaria	Korea, Rep.	Slovenia
Canada	Kuwait	Spain
Cayman Islands	Latvia	St. Kitts and Nevis
Channel Islands	Liechtenstein	St. Martin (French part)
Chile	Lithuania	Sweden
Costa Rica	Luxembourg	Switzerland
Croatia	Macao SAR, China	Taiwan, China
Curaçao	Malta	Trinidad and Tobago
Cyprus	Monaco	Turks and Caicos Islands
Czechia	Nauru	United Arab Emirates
Denmark	Netherlands	United Kingdom
Estonia	New Caledonia	United States
Faroe Islands	New Zealand	Uruguay
Finland	Northern Mariana Islands	Virgin Islands (U.S.)
France	Norway
French Polynesia	Oman
Germany	Palau

Afghanistan	Korea, Dem. People’s Rep	Somalia
Burkina Faso	Liberia	South Sudan
Burundi	Madagascar	Sudan
Central African Republic	Malawi	Syrian Arab Republic
Chad	Mali	Togo
Congo, Dem. Rep	Mozambique	Uganda
Eritrea	Niger	Yemen, Rep.
Gambia, The	Rwanda
Guinea-Bissau	Sierra Leone

Albania	Equatorial Guinea	Moldova
Algeria	Fiji	Mongolia
Argentina	Gabon	Montenegro
Armenia	Georgia	North Macedonia
Azerbaijan	Grenada	Paraguay
Belarus	Guatemala	Peru
Belize	Indonesia	Samoa
Bosnia and Herzegovina	Iran, Islamic Rep.	Serbia
Botswana	Iraq	South Africa
Brazil	Jamaica	St. Lucia
Cabo Verde	Kazakhstan	St. Vincent and the Grenadines
China	Kosovo	Suriname
Colombia	Libya	Thailand
Cuba	Malaysia	Tonga
Dominica	Maldives	Türkiye
Dominican Republic	Marshall Islands	Turkmenistan
Ecuador	Mauritius	Tuvalu
El Salvador	Mexico	Ukraine

ABOUT SEATS X MLCC

ABOUT SEATS X MLCC

Pulmonology Workshop

Oncology Workshop

High-Income Countries (HIC)

Low-Income Countries (LIC)

Upper Middle-Income Countries (UMIC)

Lower Middle-Income Countries (LMIC)

Angola	India	Papua New Guinea
Bangladesh	Jordan	Philippines
Benin	Kenya	São Tomé and Principe
Bhutan	Kiribati	Senegal
Bolivia	Kyrgyz Republic	Solomon Islands
Cambodia	Lao PDR	Sri Lanka
Cameroon	Lebanon	Tajikistan
Comoros	Lesotho	Tanzania
Congo, Rep.	Mauritania	Timor-Leste
Côte d’Ivoire	Micronesia, Fed. Sts.	Tunisia
Djibouti	Morocco	Uzbekistan
Egypt, Arab Rep.	Myanmar	Vanuatu
Eswatini	Namibia	Viet Nam
Ghana	Nepal	West Bank and Gaza
Guinea	Nicaragua	Zambia
Haiti	Nigeria	Zimbabwe
Honduras	Pakistan